Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study

Stefano Aliberti, Dejan Radovanovic, Filippo Billi, Giovanni Sotgiu, Matteo Costanzo, Tommaso Pilocane, Laura Saderi, Andrea Gramegna, Angelo Rovellini, Luca Perotto, Valter Monzani, Pierachille Santus, Francesco Blasi, Stefano Aliberti, Dejan Radovanovic, Filippo Billi, Giovanni Sotgiu, Matteo Costanzo, Tommaso Pilocane, Laura Saderi, Andrea Gramegna, Angelo Rovellini, Luca Perotto, Valter Monzani, Pierachille Santus, Francesco Blasi

Abstract

Helmet CPAP treatment fails in up to 44% of patients with moderate-to-severe hypoxaemic acute respiratory failure due to COVID-19 pneumonia https://bit.ly/3g7FAB8

Conflict of interest statement

Conflict of interest: S. Aliberti reports grants and personal fees from Bayer Healthcare, Aradigm Corporation, Grifols, Chiesi and INSMED, personal fees from AstraZeneca, Basilea, Zambon, Novartis, Raptor, Actavis UK Ltd and Horizon, outside the submitted work. Conflict of interest: D. Radovanovic has nothing to disclose. Conflict of interest: F. Billi has nothing to disclose. Conflict of interest: G. Sotgiu has nothing to disclose. Conflict of interest: M. Costanzo has nothing to disclose. Conflict of interest: T. Pilocane has nothing to disclose. Conflict of interest: L. Saderi has nothing to disclose. Conflict of interest: A. Gramegna has nothing to disclose. Conflict of interest: A. Rovellini has nothing to disclose. Conflict of interest: L. Perotto has nothing to disclose. Conflict of interest: V. Monzani has nothing to disclose. Conflict of interest: P. Santus has nothing to disclose. Conflict of interest: F. Blasi reports grants and personal fees from AstraZeneca, Chiesi, GSK, Insmed and Pfizer, grants from Bayer, personal fees from Guidotti, Grifols, Menarini, Mundipharma, Novartis, Zambon and Vertex, outside the submitted work.

References

    1. Cosentini R, Brambilla AM, Aliberti S, et al. . Helmet continous positive airway pressure vs oxygen therapy to improve oxygentaion in community-acquires pneumonia: a randomized controlled trial. Chest 2010; 138: 114–120. doi:10.1378/chest.09-2290
    1. Brambilla AM, Aliberti S, Prina E, et al. . Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia. Intensive Care Med 2014; 40: 942–949. doi:10.1007/s00134-014-3325-5
    1. Vitacca M, Nava S, Santus P, et al. . Early consensus management for non-ICU ARF SARS-CoV-2 emergency in Italy: from ward to trenches. Eur Respir J 2020; 55: 2000632.
    1. Ferioli M, Cisternino C, Leo V, et al. . Protecting healthcare workers from SARS-CoV-2 infection: practical indications. Eur Respir Rev 2020; 29: 200068. doi:10.1183/16000617.0068-2020
    1. Radovanovic D, Rizzi M, Pini S, et al. . Helmet CPAP to treat acute hypoxemic respiratory failure in patients with COVID-19: a management strategy proposal. J Clin Med 2020; 9: E1191. doi:10.3390/jcm9041191
    1. Poston JT, Patel BK, Davis AM. Management of critically ill adults with COVID-19. JAMA 2020; 323: 1839–1841.
    1. Metlay JP, Waterer GW, Long AC, et al. . Diagnosis and treatment of adults with community-acquired pneumonia. An official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 2019; 200: e45–e67. doi:10.1164/rccm.201908-1581ST
    1. Brambilla AM, Prina E, Ferrari G, et al. . Non-invasive positive pressure ventilation in pneumonia outside intensive care unit: An Italian multicenter observational study. Eur J Intern Med 2019; 59: 21–26. doi:10.1016/j.ejim.2018.09.025
    1. Ackermann M, Verleden SE, Kuehnel M, et al. . Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 2020; 383: 120–128. doi:10.1056/NEJMoa2015432
    1. Grasselli G, Zangrillo A, Zanella A, et al. . Baseline Characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 2020; 323: 1574–1581. doi:10.1001/jama.2020.5394
    1. Oranger M, Gonzalez-Bermejo J, Dacosta-Noble P, et al. . Continuous positive airway pressure to avoid intubation in SARS-CoV-2 pneumonia: a two-period retrospective case-control study. Eur Respir J 2020; 56: 2001692. doi:10.1183/13993003.01692-2020

Source: PubMed

3
Tilaa